Action 1681 CONSUN PHARMACEUTICAL GROUP LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Consun Pharmaceutical Group Limited

Actions

1681

KYG2524A1031

Marché Fermé - Hong Kong S.E.
Autres places de cotation
 10:08:22 10/05/2024 		Varia. 5j. Varia. 1 janv.
6,36 HKD +0,79% Graphique intraday de Consun Pharmaceutical Group Limited +4,61% +33,33%
07/05 Consun Pharmaceutical va octroyer environ 8,2 millions d'options sur actions dans le cadre d'un nouveau programme MT
28/03 Consun Pharmaceutical Group Limited publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Consun Pharmaceutical to Grant About 8.2 Million Share Options Under New Program
Consun Pharmaceutical Group Sees 15% Increase in 2023 Profit
Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024
Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Consun Pharmaceutical Group Limited Announces Board and Committee Changes
Consun Pharma CEO Steps Down
Consun Pharmaceutical Group Limited Announces CEO Changes
Consun Pharmaceutical Group Limited Announces Management Changes
Consun Pharmaceutical's Unit Starts Construction of Second Chinese Medicine Granule Plant
Consun Pharmaceutical's H1 Profit Rises on Higher Revenue
Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 20 September 2023
Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2022
Consun Pharmaceutical Group Limited Declares Final Dividend for the Year Ended December 31, 2022
Chinese Regulator Approves Consun Pharmaceutical's Clinical Trial for Kidney Disease Treatment
Consun Pharmaceutical Group Limited Receives Approval for Clinical Trial of Drug for SK-07 Injection
Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Consun Pharmaceutical Group Limited Proposes to Pay A Final Dividend for the Year Ended December 31, 2022, Payable on or About June 21, 2023
Consun Pharmaceutical Group Sees Surge in 2022 First-Half Profit
Consun Pharmaceutical's H1 Profit Rises on Higher Revenue
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 1681
  4. Actualités Consun Pharmaceutical Group Limited
  5. Autres langues